Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice.
Sykes
M
M
Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston 02129.
Abraham
V S
VS
Harty
M W
MW
Pearson
D A
DA
D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology*; D015704:CD4 Antigens / Q000276:immunology*; D016827:CD8 Antigens / Q000276:immunology; D006086:Graft vs Host Disease / Q000276:immunology* / Q000517:prevention & control; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000276:immunology / Q000601:surgery*; D008212:Lymphocyte Depletion; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014916:Whole-Body Irradiation
D015704:CD4 Antigens; D016827:CD8 Antigens; D000949:Histocompatibility Antigens Class II; D007376:Interleukin-2